Insight on Pharmaceuticals and Healthcare in United Kingdom

Published within

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

Type Product title / description Pub Price
Report
Report

Epidemiology: Benign Prostatic Hyperplasia – Expected to continue growing as the male population ages

Overview of benign prostatic hyperplasia definitions and a review of epidemiology literature. This module provides analysis of patient populations, a 10-year prevalent case forecast, and key patient segmentations across the seven major markets.

Published By Datamonitor
22 Jul 2011 $2800
Buy
Report
Report

Prescribing Influences: Allergic Rhinitis – Treatment tolerability remains a key differentiator

In March 2011, Datamonitor surveyed 149 ENT and allergy specialists and pulmonologists in the seven major markets. The results are analyzed with key opinion leader interviews and secondary sources to assess allergic rhinitis prescribing influences.

Published By Datamonitor
25 Jul 2011 $2800
Buy
Report
Report

Treatment Algorithms: Type 2 Diabetes – Novel classes drive fragmentation of treatment choices in type 2 diabetes

Datamonitor reports average patient population and prescribing behavior by therapy line in the seven major markets, as well as analysis of therapy switching, patient share by drug class, and class use trends, based on a 199-physician survey.

Published By Datamonitor
27 Jul 2011 $4800
Buy
Report
Report

Hot Topics: Obesity – Three Complete Response Letters and one Advisory Committee meeting

This case study explores the clinical and commercial ramifications of US Food & Drug Administration Complete Response Letters issued to Vivus, Arena and Orexigen, the sponsors of late stage obesity drugs Qnexa, Lorquess and Contrave.

Published By Datamonitor
27 Jul 2011 $2800
Buy
Report
Report

Hot Topics: Obesity – The US FDA and cardiovascular risk analysis: the AdComm Cometh

A US FDA obesity drug cardiovascular safety advisory committee meeting mooted for 2012 means obesity drug safety requirements could change dramatically. Two years after a similar scene in diabetes, this analysis profiles some pertinent precedents.

Published By Datamonitor
27 Jul 2011 $2800
Buy
Report
Report

Key Companies: Depression - Leading players must adapt to remain competitive

This report identifies the leading players that are active in the depression pharmaceutical market, evaluating trends in corporate strategy and discussing the impact of key recent licensing deals.

Published By Datamonitor
02 Aug 2011 $2800
Buy
Report
Report

Epidemiology: Attention Deficit Hyperactivity Disorder – Adult prevalence continues to be under-reported

Overview of ADHD, disorder definition, and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
05 Aug 2011 $2800
Buy
Report
Report

R&D Trends: Influenza vaccines - Commoditization limits opportunities in a crowded market

This module discusses R&D Trends in influenza vaccine development in the seven major markets (the US, Japan, France, Germany, Spain, Italy, and the UK).

Published By Datamonitor
05 Aug 2011 $2800
Buy
Report
Report

Epidemiology: Obesity – Set to reach pandemic levels as overweight/obese children become adults

Overview of obesity definitions and a review of epidemiology literature. This report provides and in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
08 Aug 2011 $2800
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally.

Published By Datamonitor
09 Aug 2011 $1520
Buy

« | ... | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | ... | » »|

No help is available.